NAN Nanoscience

TIDMTMZ

RNS Number : 7481C

Toumaz Limited

20 October 2015

20 October 2015

Toumaz Limited

New GBP5m banking facility

Toumaz Limited (AIM: TMZ, 'Toumaz', or the 'Group'), a pioneer in low-power, wireless semiconductor technologies for healthcare and digital audio, has signed a three year GBP5m term loan with Clydesdale Bank Growth Finance. This is a senior term loan with capital amortisation commencing from June 2016 with no dilution to the equity.

Anthony Sethill, CEO of Toumaz Group, said:

"As we stated in our half years results in September 2015, we expect to be cash generative from the middle of 2016. This loan provides greater resilience to our existing reserves."

Enquiries

 
 Toumaz Limited                              +44 (0) 207 391 0630 
 Anthony Sethill, Chief Executive Officer 
  Jonathan Apps, Chief Financial Officer 
 
 Peel Hunt LLP (Nominated Adviser and 
  Broker)                                    +44 (0) 207 418 8900 
 Richard Kauffer/Euan Brown 
 
 Instinctif Partners                         +44 (0) 207 457 2020 
 Adrian Duffield/Lauren Foster 
 

About Toumaz (www.toumaz.com)

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for digital audio and healthcare. The company has two divisions, Frontier Silicon and Sensium Healthcare. Frontier Silicon provides chips, modules and software for digital radio and connected audio devices. Sensium Healthcare develops wireless solutions for patient monitoring.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFFDIVLALIE

(END) Dow Jones Newswires

October 20, 2015 02:00 ET (06:00 GMT)

Nanoscience (LSE:NAN)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025

Nanoscience (LSE:NAN)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025